VLGC Insider Trading Activity and SEC Form 4 Filings
VLGC insider trading summary
No open-market insider purchases or sales of Virologic Inc (VLGC) have been reported on SEC Form 4 in the past 12 months.
Latest VLGC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 24, 2005 | Kathy L Hibbs | VP, General Counsel | Buy | $7K (3,006 @ $2.46) |
| Aug 22, 2005 | Jeannette Whitecomb | VP, Operations | Buy | $23K (10,000 @ $2.30) |
| Aug 19, 2005 | Cristina Kepner | Director | Buy | $58K (25,000 @ $2.32) |
| Aug 5, 2005 | William D Young | Chairman, CEO | Buy | $12K (5,000 @ $2.36) |
| Aug 5, 2005 | William D Young | Chairman, CEO | Buy | $12K (5,000 @ $2.37) |
| Aug 5, 2005 | William D Young | Chairman, CEO | Buy | $12K (5,000 @ $2.37) |
| Aug 5, 2005 | William D Young | Chairman, CEO | Buy | $18K (7,500 @ $2.37) |
| Aug 5, 2005 | William D Young | Chairman, CEO | Buy | $6K (2,500 @ $2.37) |
| Jul 6, 2005 | Sharat Singh | CTO, Oncology | Sell | $22K (8,500 @ $2.53) |
| Jun 1, 2005 | Sharat Singh | CTO, Oncology | Sell | $23K (8,500 @ $2.65) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.